Overview

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso...

Open

$599.03

Prior close

$598.72

Today's high

$599.84

Today's low

$592.84

52 Week high

$609.99

52 Week low

$430.02

News

Zacks Investment Research • 3 days ago • UTHR

SGIOY vs. UTHR: Which Stock Is the Better Value Option?

Zacks Investment Research • 5 days ago • UTHR

Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out for

FXEmpire • 6 days ago • UTHR

United Therapeutics Rising Ahead of Next Earnings Report

Zacks Investment Research • 19 days ago • UTHR

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Proactive Investors • 19 days ago • UTHR

Liquidia shares surge 25% as settlement ends United Therapeutics litigation